NuCana (NCNA) Other Non-Current Assets (2021 - 2023)

NuCana (NCNA) reported Other Non-Current Assets of $3.2 million for Q2 2023, down 0.94% on a YoY basis from $3.3 million in Q2 2022, and up 0.55% sequentially from $3.2 million in Q1 2023.

NuCana (NCNA) Other Non-Current Assets (2021 - 2023) Analysis & Trends

NuCana (NCNA) has 3 years of Other Non-Current Assets data on file, last reported at $3.2 million in Q2 2023.

  • For the quarter ending Q2 2023, Other Non-Current Assets fell 0.94% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2023 stood at $3.2 million (down 0.94% YoY), and the FY2022 full-year result was $3.3 million, down 4.95% from the prior year.
  • Other Non-Current Assets climbed to $3.2 million in Q2 2023, from $3.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.6 million in Q3 2021 to a low of $3.1 million in Q3 2022.
  • A 3-year average of $3.3 million and a median of $3.3 million in 2023 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets fell 12.7% in 2022 and dropped 0.94% in 2023, its largest moves.
  • Tracing NCNA's Other Non-Current Assets over 3 years: stood at $3.4 million in 2021, then fell by 8.06% to $3.1 million in 2022, then climbed by 3.19% to $3.2 million in 2023.
  • Business Quant data shows NCNA's Other Non-Current Assets at $3.2 million in Q2 2023, $3.2 million in Q1 2023, and $3.1 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 63.55 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 3.25 Mn
Mar 31, 2023 3.23 Mn
Dec 31, 2022 3.15 Mn
Sep 30, 2022 3.13 Mn
Jun 30, 2022 3.28 Mn
Mar 31, 2022 3.43 Mn
Dec 31, 2021 3.42 Mn
Sep 30, 2021 3.58 Mn